Cargando…
The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
Receptor-interacting protein (RIP)3 is a critical regulator of necroptosis and has been demonstrated to be associated with various diseases, suggesting that its inhibitors are promising in the clinic. However, there have been few RIP3 inhibitors reported as yet. B-Raf(V600E) inhibitors are an import...
Autores principales: | Li, J-X, Feng, J-M, Wang, Y, Li, X-H, Chen, X-X, Su, Y, Shen, Y-Y, Chen, Y, Xiong, B, Yang, C-H, Ding, J, Miao, Z-H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611716/ https://www.ncbi.nlm.nih.gov/pubmed/24901049 http://dx.doi.org/10.1038/cddis.2014.241 |
Ejemplares similares
-
Clinical Significance of PEAK1 Expression and BRAF V600E Mutation in Papillary Thyroid Cancer
por: Li, P., et al.
Publicado: (2022) -
Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury
por: Cruz, Shelly A., et al.
Publicado: (2018) -
B-RAF(V600E) Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury
por: Sugaya, Takehiro, et al.
Publicado: (2019) -
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
por: Subbiah, Vivek, et al.
Publicado: (2023) -
Metabonomic Analysis of
Bombyx mori
(Heterocera: Bombysidae) Treated With Acetaminophen
por: Yin, W. M., et al.
Publicado: (2014)